The global Platinum based Cancer Drug market was valued at 136.18 Million USD in 2021 and will grow with a CAGR of 3.72% from 2021 to 2027, based on newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017. Asia-Pacific is the largest market, with a sales market share nearly 53% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.

By Market Verdors:


  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddys Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

By Types:

  • Cisplatin
  • Oxaliplatin
  • Carboplatin

By Applications:

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer

Key Indicators Analysed

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

  • To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
  • Assess the production processes, major issues, and solutions to mitigate the development risk.
  • To understand the most affecting driving and restraining forces in the market and its impact in the global market.
  • Learn about the market strategies that are being adopted by leading respective organizations.
  • To understand the future outlook and prospects for the market.
  • Besides the standard structure reports, we also provide custom research according to specific requirements

Table of content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Platinum based Cancer Drug Revenue

1.4 Market Analysis by Type

1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Cisplatin

1.4.3 Oxaliplatin

1.4.4 Carboplatin

1.5 Market by Application

1.5.1 Global Platinum based Cancer Drug Market Share by Application: 2022-2027

1.5.2 Colorectal?Cancer

1.5.3 Ovarian?Cancer

1.5.4 Lung?Cancer

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Platinum based Cancer Drug Market

1.8.1 Global Platinum based Cancer Drug Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Platinum based Cancer Drug Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Platinum based Cancer Drug Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Platinum based Cancer Drug Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Platinum based Cancer Drug Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Platinum based Cancer Drug Sales Volume Market Share by Region (2016-2021)

3.2 Global Platinum based Cancer Drug Sales Re

276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global Platinum based Cancer Drug Market Outlook 2022

Platinum based Cancer Drug Market – Global Outlook and Forecast 2021-2027

Global Platinum based Cancer Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Platinum based Cancer Drug Market Research Report 2021 Professional Edition

Leave a Reply

Your email address will not be published. Required fields are marked *